A Phase 2 trial testing experimental therapy CAL101 in people with IPF is recruiting participants. CAL101 has been granted ...
Columnist Samuel Kirton has nothing but praise for caregivers, who represent the best of what is right in the world.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback